Zensar's Nomination Committee approved the allotment of 1,200 equity shares to employees upon ESOP exercise on May 07, 2026.
The company's issued and subscribed share capital increased to ₹45.50 crore, comprising 227.50 million shares post-allotment.
This is a routine regulatory disclosure filed with the BSE and NSE under listing obligations.